Skip to content

Moelis & Co

US · MC #2267 by market cap Listed 1970
56.15 +0.10 +0.18%
Live - 5344 symbols - heartbeat 337s ago · 2026-10-08 07:40
Pre-market 56.15 0.00%
After-hours 56.15 0.00%
Overnight 56.15 0.00%
Market cap
4.16B
P/B
8.22
EPS
2.94
Reader sentiment Are you bullish or bearish on MC?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Mixed / stable
  • Total institutional ownership (as a % of shares) was little changed.

Institutional ownership

Held by institutions
109.41% +0.01pp
Institutions
462
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund94.91%
Public Company5.33%
Hedge Fund4.67%
Government Pension Fund2.01%
Individual/Insider1.01%
Insurance Company0.76%
Private Company0.70%
Sovereign Wealth Fund0.60%
Family Office/Trust0.35%

Top holders as of 2026-06-30

BlackRock 12.23% · 9.06M sh
Kayne Anderson Rudnick Investment Management, LLC 7.31% · 5.41M sh
Vanguard Portfolio Management, LLC 6.06% · 4.49M sh
Vanguard Capital Management, LLC 5.25% · 3.89M sh
Wasatch Advisors LP 4.38% · 3.25M sh
State Street Global Advisors 4.11% · 3.04M sh
Charles Schwab Investment Management 3.99% · 2.96M sh
The London Company of Virginia, LLC 3.77% · 2.79M sh
Geode Capital Management, LLC 3.19% · 2.36M sh
Columbia Management Investment Advisers, LLC 3.17% · 2.34M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 47 buys · 2 sells

NameRoleStake
Eric Cantor Vice Chairperson & Managing Director 0.32%
Kenneth Moelis Chairperson & CEO 0.29%
Navid Mahmoodzadegan Co-Founder, Founding Partner, Co-President & MD 0.27%
Jeffrey Raich Co-Founder, Co-President & MD 0.07%
Joseph Simon Chief Financial Officer 0.03%
Kate Ciafone Co- Founder & COO 0.01%
Laila Worrell Independent Director 0.01%
Kenneth Shropshire Lead Independent Director 0.01%
Christopher Callesano Principal Accounting Officer, Corporate Controller & MD of New York 0.00%
Osamu Watanabe Chief Compliance Officer 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-16 Kenneth Shropshire Lead Independent Director Other Acquisition +2 --
2026-09-16 Kenneth Shropshire Lead Independent Director Other Acquisition +18 --
2026-09-16 Kenneth Shropshire Lead Independent Director Other Acquisition +20 --
2026-09-16 Osamu Watanabe Chief Compliance Officer Other Derivative Acquisition +15 --
2026-09-16 Osamu Watanabe Chief Compliance Officer Other Derivative Acquisition +23 --
2026-09-16 Osamu Watanabe Chief Compliance Officer Other Derivative Acquisition +44 --
2026-09-16 Osamu Watanabe Chief Compliance Officer Other Derivative Acquisition +52 --
2026-09-16 Osamu Watanabe Chief Compliance Officer Other Derivative Acquisition +58 --
2026-09-16 Osamu Watanabe Chief Compliance Officer Other Derivative Acquisition +66 --
2026-09-16 Eric Cantor Vice Chairperson & Managing Director Other Derivative Acquisition +74 --
2026-09-16 Eric Cantor Vice Chairperson & Managing Director Other Derivative Acquisition +77 --
2026-09-16 Eric Cantor Vice Chairperson & Managing Director Other Derivative Acquisition +142 --
2026-09-16 Eric Cantor Vice Chairperson & Managing Director Other Derivative Acquisition +195 --
2026-09-16 Eric Cantor Vice Chairperson & Managing Director Other Derivative Acquisition +225 --
2026-09-16 Kate Ciafone Co- Founder & COO Other Derivative Acquisition +15 --
2026-09-16 Kate Ciafone Co- Founder & COO Other Derivative Acquisition +44 --
2026-09-16 Christopher Callesano Principal Accounting Officer, Corporate Controller & MD of New York Other Derivative Acquisition +4 --
2026-09-16 Christopher Callesano Principal Accounting Officer, Corporate Controller & MD of New York Other Derivative Acquisition +13 --
2026-09-16 Christopher Callesano Principal Accounting Officer, Corporate Controller & MD of New York Other Derivative Acquisition +14 --
2026-09-16 Laila Worrell Independent Director Other Acquisition +17 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 07:40:24 · For reference only, not investment advice and not tailored to your situation.